Treatment of Autistic Children Using NAET Procedures

This study has been completed.

First Received on January 12, 2006. Last Updated on May 4, 2007 History of Changes

Sponsor:	Nambudripad's Allergy Research Foundation
Collaborator:	Anonymous
Information provided by:	Nambudripad's Allergy Research Foundation
ClinicalTrials.gov Identifier:	NCT00277407

Purpose

Purpose of this study is to determine whether NAET procedures are effective in the treatment of children with allergy-related autism spectrum disorders in restoring their verbal and nonverbal communication.
Hypothesis: Children in the experimental group will show a significant improvement over the control group in verbal and nonverbal communication as most food allergen groups, environmental allergen groups, childhood immunizations, and some other relevant allergenic substances are desensitized in a systematic way using NAET® procedures within the specified period of study.

Condition	Intervention
Autism Food Allergies	Procedure: NAET with acupressure and/or chiropractic procedures

Study Type:	Interventional
Study Design:	Allocation: Non-Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment
Official Title:	An Investigation Into the Outcome of NAET Treatment on Children With Allergy-Related Autism Spectrum Disorders in a Multi-Clinical Setting.

Resource links provided by NLM:

MedlinePlus related topics: Allergy Autism Food Allergy

U.S. FDA Resources

Further study details as provided by Nambudripad's Allergy Research Foundation:

Primary Outcome Measures:

Improvement in verbal and norverbal communication [ Time Frame: Twenty-four months from the starting date (approximately may 2008) ]

Secondary Outcome Measures:

Reduction of commonly seen autistic traits [ Time Frame: Twenty-four months from starting dat (May 2008) ]

Enrollment:	48
Study Start Date:	June 2006
Study Completion Date:	May 2007

Show Detailed Description

Eligibility

Ages Eligible for Study:	3 Years to 10 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

all subjects (control and treatment group) should demonstrate typical autistic symptoms before beginning NAET® treatments: made no eye contact, unable to communicate verbally or nonverbally. All subjects should bring in a proof of established diagnosis of autism spectrum disorder by a conventional physician.

Exclusion Criteria:

Any child that has a history of various complications of illness other than autism spectrum disorder would be disqualified. Any patient who has any of the following conditions will also be disqualified.

Previous surgeries, congenital deformities of heart, lung, liver, brain, kidney, etc.
Any type of cancer
Aids
Any physically debilitating disorders and diagnosed mental retardation, Down’s syndrome, etc.
Children with the history of severe allergies or anaphylactic reactions will be exclued.

-

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00277407

Locations

United States, California
NAET Pain Clinic
Buena Park, California, United States, 90621

Sponsors and Collaborators

Nambudripad's Allergy Research Foundation

Anonymous

Investigators

Principal Investigator:

Devi S. Nambudripad, DCLAcPhD

NAR Foundation

More Information

Additional Information:

NAR foundation is a nonprofit allergy research foundation This link exits the ClinicalTrials.gov site

No publications provided

ClinicalTrials.gov Identifier:	NCT00277407 History of Changes
Other Study ID Numbers:	MulticlinicalAutism Study, NARFoundationAutismStudy2006
Study First Received:	January 12, 2006
Last Updated:	May 4, 2007
Health Authority:	United States: Institutional Review Board

Keywords provided by Nambudripad's Allergy Research Foundation:

NAET
Chiropractic procedures
Acupuncture/acupressure
Treatment of Autism by holistic procedures
Food and Vaccination allergy

Additional relevant MeSH terms:

Hypersensitivity
Autistic Disorder
Food Hypersensitivity
Child Development Disorders, Pervasive

Immune System Diseases
Mental Disorders Diagnosed in Childhood
Mental Disorders
Hypersensitivity, Immediate

ClinicalTrials.gov processed this record on February 13, 2012